Electromuscular Stimulation Therapy as a Prophylactic Method to Reduce Thromboses Related to PICC Catheters in Patients Hospitalized in Critical Care Units.

Launched by INSTITUT D'INVESTIGACIÓ BIOMÈDICA DE GIRONA DR. JOSEP TRUETA · Nov 13, 2023

Keywords

ClinConnect Summary

This clinical trial is studying whether a treatment called Electromuscular Stimulation Therapy can help prevent blood clots in patients who have a specific type of catheter called a PICC (peripherally inserted central catheter) while they are in critical care units. Blood clots related to these catheters can be a common problem, and this trial aims to see if adding this therapy—where small electrical pulses stimulate the muscles—can reduce the risk of developing clots.

To participate in this trial, patients need to be between 18 and 80 years old and must be admitted to a critical care unit with a PICC catheter placed by hospital staff. They should be able to give their consent to join the study. Participants will be randomly assigned to either receive the electrostimulation therapy or just the usual care for their catheter. They can expect to attend therapy sessions five days a week for 20 minutes each, along with regular check-ups to monitor their condition. This research is important because it could lead to better care for patients with PICC catheters and reduce the risks associated with them.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients admitted to the critical unit with a PICC whose insertion is done by the EIAV of the same hospital.
• • Patients between 18 and 80 years of age.
• • Treatments related to the device protocolized by the same hospital as the EIAV implanter.
• Exclusion Criteria:
• • Patients who do not sign informed consent.
• • Patients with pacemakers and/or implantable automatic defibrillators.
• • Patients with epilepsy.
• • Removal of the device within the first 15 days after insertion.
• • Hospital discharge, transfer to another hospital or death lethalis during the duration of the study.
• • Displacement of the tip of the catheter outside the lower ⅓ of the superior vein cava during the study period.
• • Presence of lesions in the place where the electrodes must be placed to perform the electrostimulation therapy.
• • Non-compliance with catheter monitoring: Of the five ultrasound controls protocolized in the study, 80% were not complied with.